A Multinational Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters in Healthy Women

Clinical trial NCT01388491 · COMPLETED

Trial details

NCT number: NCT01388491
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hemostasis Oral Contraceptive

Start date: 2011-10-31
Primary completion: 2012-09-30
Enrollment: 293

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.